297 related articles for article (PubMed ID: 6085357)
1. Large arteries in hypertension: acute effects of a new calcium entry blocker, nitrendipine.
Levenson J; Simon AC; Safar ME; Bouthier J; Maarek BC
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1006-10. PubMed ID: 6085357
[TBL] [Abstract][Full Text] [Related]
2. Acute and long-term effects of nitrendipine on resting and exercise hemodynamics in essential hypertension.
Nannan ME; Melin JA; Vanbutsele RJ; Lavenne F; Detry JM
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1043-8. PubMed ID: 6085364
[TBL] [Abstract][Full Text] [Related]
3. Acute hemodynamic effects of nitrendipine in chronic congestive heart failure.
Olivari MT; Levine TB; Cohn JN
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1002-5. PubMed ID: 6085356
[TBL] [Abstract][Full Text] [Related]
4. Effects of a calcium channel blocker on cardiac output distribution in conscious hypertensive dogs.
Knight DR; Kirby DA; Vatner SF
Hypertension; 1985; 7(3 Pt 1):380-5. PubMed ID: 3158603
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of systemic hemodynamic response to a new calcium entry blocker, nitrendipine.
Fouad FM; Aboul-Khair M; Tarazi RC
J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S383-6. PubMed ID: 6184573
[TBL] [Abstract][Full Text] [Related]
6. Treatment for one year with perindopril: effect on cardiac mass and arterial compliance in essential hypertension.
Asmar RG; Journo HJ; Lacolley PJ; Santoni JP; Billaud E; Levy BI; Safar ME
J Hypertens Suppl; 1988 Dec; 6(3):S33-9. PubMed ID: 3225688
[TBL] [Abstract][Full Text] [Related]
7. Differential responses of the heart and vasculature to chronic blood pressure reduction in essential hypertension.
Lafleche A; Gautier S; Topouchian J; Wilmet CS; Girerd X; Safar ME; Benetos A
Clin Pharmacol Ther; 1998 Jul; 64(1):96-105. PubMed ID: 9695724
[TBL] [Abstract][Full Text] [Related]
8. The effect of acute and chronic nicardipine therapy on forearm arterial haemodynamics in essential hypertension.
Levenson J; Simon AC; Bouthier J; Maarek BC; Safar ME
Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):107S-113S. PubMed ID: 4027144
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive effects on blood pressure at rest and during exercise of calcium antagonists, beta-receptor blockers, and their combination in hypertensive patients.
Franz IW; Wiewel D
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1037-42. PubMed ID: 6085363
[TBL] [Abstract][Full Text] [Related]
10. [Central and peripheral hemodynamic effects of nifedipine administered orally and sublingually in essential arterial hypertension].
Levenson J; Simon AC; Bouthier JD; Maarek BC; Safar ME
Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():33-9. PubMed ID: 3937504
[TBL] [Abstract][Full Text] [Related]
11. Long-term effectiveness of BAY e 5009-nitrendipine in the treatment of mild and moderate arterial hypertension.
Esper RJ; Esper RC; Baglivo HP; Castro JM; Rohwedder RW; Menna J
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1096-9. PubMed ID: 6085374
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive and vasodilating effects of acute medroxalol, a new beta-blocker with beta-2-adrenergic receptor stimulation.
Simon A; Levenson J; Bouthier J; Merli I
J Pharmacol; 1986; 17(3):331-7. PubMed ID: 3795977
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive therapy with the long-acting calcium antagonist nitrendipine.
Müller FB; Bolli P; Erne P; Block LH; Kiowski W; Bühler FR
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1073-6. PubMed ID: 6085370
[TBL] [Abstract][Full Text] [Related]
14. Nitrendipine and other calcium entry blockers (calcium antagonists) in hypertension.
Kazda S; Garthoff B; Knorr A
Fed Proc; 1983 Feb; 42(2):196-200. PubMed ID: 6822291
[TBL] [Abstract][Full Text] [Related]
15. Combined effects of sex and hypertension on the geometrical design of large arteries. Sexual differences in normal and hypertensive forearm arteries.
Simon AC; Levenson J; Cambien F; Bouthier J
J Clin Hypertens; 1987 Dec; 3(4):617-23. PubMed ID: 3330990
[TBL] [Abstract][Full Text] [Related]
16. Acute effect of labetalol on hypertensive brachial artery.
Pithois-Merli IM; Cournot AX; Georges DR; Pappo M; Safar ME
J Clin Hypertens; 1987 Dec; 3(4):479-86. PubMed ID: 3453384
[TBL] [Abstract][Full Text] [Related]
17. Parallel reduction of calcium-influx-dependent vasoconstriction and platelet-free calcium concentration with calcium entry and beta-adrenoceptor blockade.
Bolli P; Erne P; Hulthén UL; Ritz R; Kiowski W; Ji BH; Bühler FR
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S996-1001. PubMed ID: 6085391
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with long-term nitrendipine treatment in essential hypertension.
Tourkantonis A; Lasaridis A; Settas L
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1090-5. PubMed ID: 6085373
[TBL] [Abstract][Full Text] [Related]
19. The calcium channel blocker nitrendipine in single- and multiple-agent antihypertensive regimens: preliminary report of a multicenter study.
Weber MA; Drayer JI
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1077-84. PubMed ID: 6085371
[TBL] [Abstract][Full Text] [Related]
20. Regression of cardiovascular structural changes after long-term antihypertensive treatment with the calcium antagonist nitrendipine.
Agabiti-Rosei E; Muiesan ML; Rizzoni D; Romanelli G; Beschi M; Castellano M
J Cardiovasc Pharmacol; 1991; 18 Suppl 5():S5-9. PubMed ID: 1725798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
